Scientists have long known that the Alzheimer's brain often features abnormal plaques and tangles, and recent studies have ...

Scientists have long known that the Alzheimer's brain often features abnormal plaques and tangles, and recent studies have ...

The Aβ/fibrinogen complex is implicated in Alzheimer's progression, highlighting vascular health's role and offering new ...

Investigating tirzepatide's role in Alzheimer's reveals its potential to improve brain function and reduce inflammation, ...

POTOMAC, MD / ACCESS Newswire / June 23, 2025 / IGC Pharma, Inc. ("IGC", or the "Company") (NYSE American:IGC) today announced the addition of a new clinical trial site at Tekton Research in Yukon, ...

Ventyx Biosciences has shared promising top-line results from a phase 2a study of its investigational central nervous system ...

"The submission of PORTICO-2 to the FDA marks a major step forward for Oryzon and for the field of neuropsychiatry of personality disorders," said Carlos Buesa, Chief Executive Officer of Oryzon.

Roche to advance prasinezumab into phase III development for early-stage Parkinson's disease: Basel Tuesday, June 17, 2025, 09:00 Hrs [IST] Roche announced its decision to proceed ...

A new study has examined brains affected by PTSD at the single-cell level, uncovering distinct genetic alterations that may ...

A groundbreaking analysis from leading British universities has uncovered surprising links between everyday medications and ...